ABCA4 rs3918342: Understanding Your Retinal Health Marker
rs3918342 is a common single nucleotide polymorphism located in an intronic non-coding region of the ABCA4 gene on chromosome 1. While rare loss-of-function variants in ABCA4 cause autosomal recessive Stargardt disease and related retinopathies, rs3918342 has been studied primarily as a benign background variant and potential genetic modifier. Current evidence linking this variant independently to vision disorders remains limited and non-diagnostic.
What each genotype means
Typical retinal risk profile
You carry two copies of the common C allele for this intronic ABCA4 site. This genotype represents the baseline background state in general populations and is not considered a pathogenic or causative variant for retinal dystrophies. No altered retinal risk or modifier effect has been linked specifically to this genotype alone.
Found in approximately 50% to 65% of individuals of European descent, representing the most common genotype across most global populations.
Heterozygous carrier of minor allele
You carry one copy of the common T allele alongside the standard C allele. Published research evaluating this intronic variant has found no conclusive primary disease-causing effects, though common variants in ABCA4 are occasionally studied as potential modifiers in retinal cohorts. Carrier status for this single non-coding variation is not diagnostic of Stargardt disease or retinal dystrophy.
Carried by approximately 35% to 45% of individuals in European-ancestry populations.
Homozygous minor allele
You have two copies of the T allele at this intronic ABCA4 position. Current published evidence indicates this is a common benign polymorphism rather than an autonomous driver of monogenic retinal disease. Because scientific evidence linking it to altered macular risk remains limited and non-diagnostic, it does not suggest a genetic diagnosis on its own.
Present in roughly 4% to 9% of individuals of European ancestry, and less frequent in East Asian populations.
Genomic Location and Variant Characteristics
The rs3918342 polymorphism is situated within an intron of the ATP-binding cassette subfamily A member 4 (ABCA4) gene, located on the short arm of human chromosome 1. Because it resides in an intronic intervening sequence rather than an exon, it does not alter the amino acid sequence of the encoded protein. In genome reference assemblies, this variant is characterized by an exchange between an adenine (A) nucleotide and a guanine (G) nucleotide. Genetic databases such as [NCBI dbSNP](https://www.ncbi.nlm.nih.gov/snp/rs3918342) catalog rs3918342 as a frequent natural polymorphism across human populations. Because intronic variations do not directly alter protein structures, researchers typically evaluate whether such sites disrupt canonical or cryptic splicing mechanisms or lie within regulatory enhancers. However, in the case of rs3918342, standard clinical databases including [NCBI ClinVar](https://www.ncbi.nlm.nih.gov/clinvar/?term=rs3918342) view it primarily as a benign or neutral variation rather than an overt, monogenic cause of severe retinal disease.
The Biological Role of the ABCA4 Gene
The ABCA4 gene provides instructions for producing an essential flippase transporter protein localized to the outer segment discs of photoreceptor cells, including both rod and cone cells in the retina. The protein facilitates the clearance of N-retinylidene-phosphatidylethanolamine, a reactive intermediate produced during the visual phototransduction cycle when light strikes retinal pigment molecules. By transporting these lipid-retinoid conjugates across disc membranes, ABCA4 enables the recycling of vitamin A derivatives and prevents the toxic buildup of bisretinoid compounds, such as lipofuscin. As reviewed in [PMC Retinal Disease Overview](https://pmc.ncbi.nlm.nih.gov/articles/PMC7544654), when ABCA4 function is severely disrupted by biallelic pathogenic mutations, lipofuscin accumulates inside retinal pigment epithelium (RPE) cells, leading to progressive cell death and conditions such as Stargardt disease (STGD1), cone-rod dystrophy, or retinitis pigmentosa. The physiological integrity of this pathway is vital for preserving clear central vision and long-term macular health.
Evaluating Research Evidence and Modifier Hypotheses
Severe retinal degenerations caused by ABCA4 follow an autosomal recessive inheritance pattern, requiring two pathogenic mutations in trans to cause clinical Stargardt disease, as outlined in [NCBI Bookshelf Stargardt Disease](https://www.ncbi.nlm.nih.gov/books/NBK587351). In genetic research, common variants such as rs3918342 have been evaluated to investigate whether they act as genetic modifiers that alter disease expressivity, age of onset, or susceptibility to age-related macular degeneration (AMD). Nevertheless, the current scientific evidence associating rs3918342 directly with altered vision outcomes is strictly limited and inconclusive. Unlike recognized hypomorphic alleles that cause late-onset disease when paired with severe mutations, rs3918342 has not demonstrated consistent independent disease penetrance or measurable molecular dysfunction in functional assays. Association studies exploring intronic markers in large cohorts often find that common variants reflect neutral linkage disequilibrium rather than causal biological mechanisms. As a result, major clinical genetics bodies do not treat rs3918342 as a standalone pathogenic risk factor.
Population Frequency and Ancestral Distribution
Data from large-scale reference datasets, including the Genome Aggregation Database (gnomAD), indicate that rs3918342 is a common polymorphism worldwide. In populations of European ancestry, the minor allele demonstrates a frequency generally ranging between 0.20 and 0.30, meaning that between 20% and 30% of surveyed chromosomes carry this variant. The variant is also observed in varying frequencies across other global ancestries, including African, Admixed American, and Asian cohorts. Because pathogenic variants underlying rare Mendelian diseases are under strong purifying selection and usually maintain an allele frequency well below 0.01 (1%), the high population prevalence of rs3918342 strongly supports its classification as a benign or tolerated sequence variant in the general human population.
Clinical Limitations and Personal Context
Direct-to-consumer genetic panels or raw genomic data files frequently report common variants like rs3918342, which can cause unwarranted anxiety if interpreted without professional context. It is essential to recognize that possessing one or two copies of a common ABCA4 intronic polymorphism does not constitute a diagnosis of Stargardt disease, macular degeneration, or any visual impairment. Diagnostic assessments for retinal dystrophies require comprehensive clinical examinations—such as optical coherence tomography (OCT), fundus autofluorescence, and electroretinography—combined with targeted, high-depth diagnostic sequencing that filters for verified pathogenic variants. Individuals concerned about their personal vision, who notice changes in central visual acuity, or who have a family history of juvenile or adult macular dystrophies should seek evaluation from an ophthalmologist or a board-certified genetic counselor rather than drawing conclusions from individual research-grade SNP findings.
How common is this variant?
The rs3918342 variant is a common human polymorphism, exhibiting a minor allele frequency of approximately 0.20 to 0.30 in populations of European ancestry and present across diverse global groups in gnomAD.
Frequently asked questions
Does having the rs3918342 variant mean I have Stargardt disease?
No, having rs3918342 does not mean you have Stargardt disease. Stargardt disease is a rare recessive disorder caused by specific pathogenic mutations that disrupt the ABCA4 protein, whereas rs3918342 is a common intronic variant found in many completely healthy individuals.
Can rs3918342 tell me if I will develop macular degeneration?
Currently, there is no strong clinical evidence showing that rs3918342 reliably predicts the development of age-related macular degeneration. Age-related macular degeneration is a complex condition influenced by aging, lifestyle factors, and established risk loci in other genomic regions.
Why is rs3918342 studied if it is benign?
Researchers investigate variants across the entire ABCA4 locus to explore whether non-coding differences modify the severity of existing pathogenic mutations or influence RNA splicing. Studying common markers also helps geneticists map genomic diversity and exclude benign variations during clinical diagnostic screening.
What should I do if this variant appeared in my direct-to-consumer genetic test?
You do not need to take any medical action based on this finding alone, as it represents normal human variation. If you experience visual symptoms or have a family history of inherited eye disease, you should consult an eye specialist or a genetic counselor for formal clinical testing.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3918342?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCA4
A variant in the ABCA4 gene associated with Stargardt disease.
Pathogenic missense variant in ABCA4 causing autosomal recessive Stargardt disease and cone-rod dystrophy.
Genomic variant within the ATP-binding cassette retinal transporter ABCA4 locus implicated in retinal degenerations and macular disease.
Known as the Gly1961Glu (G1961E) variant in ABCA4, a prevalent hypomorphic mutation contributing to late-onset Stargardt disease and cone-rod dystrophy.
A well-documented pathogenic missense change in ABCA4 causing autosomal recessive Stargardt disease and cone-rod dystrophy.
Pathogenic missense variant in ABCA4 (p.Leu541Pro) causing Stargardt disease and juvenile macular dystrophy.